ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Consistent with the in vitro results in cell lines, SH2-U-box downregulated BCR-ABL-dependent downstream signaling and inhibits cell growth in K562- or K562R-xenografts, as well as primary CML cells.